Tang Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,000
| Closed | -$5.17M | – | 106 |
|
|
2023
Q4 | $5.17M | Sell |
16,000
-8,000
| -33% | -$2.58M | 0.48% | 53 |
|
|
2023
Q3 | $8.6M | Buy |
24,000
+8,000
| +50% | +$2.87M | 1.21% | 26 |
|
|
2023
Q2 | $6.07M | Hold |
16,000
| – | – | 0.89% | 33 |
|
|
2023
Q1 | $7.66M | Sell |
16,000
-5,000
| -24% | -$2.4M | 1.14% | 30 |
|
|
2022
Q4 | $8.83M | Sell |
21,000
-43,000
| -67% | -$18.1M | 1.28% | 24 |
|
|
2022
Q3 | $26.7M | Buy |
64,000
+5,000
| +8% | +$2.09M | 3.27% | 8 |
|
|
2022
Q2 | $29.2M | Buy |
59,000
+19,000
| +48% | +$9.41M | 4.43% | 8 |
|
|
2022
Q1 | $22.5M | Buy |
+40,000
| New | +$22.5M | 4.51% | 5 |
|
|
2020
Q4 | – | Sell |
-40,000
| Closed | -$20.6M | – | 12 |
|
|
2020
Q3 | $20.6M | Sell |
40,000
-40,000
| -50% | -$20.6M | 3.73% | 7 |
|
|
2020
Q2 | $36.1M | Hold |
80,000
| – | – | 3.51% | 7 |
|
|
2020
Q1 | $28M | Buy |
+80,000
| New | +$28M | 3.94% | 7 |
|